MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial

CONCLUSIONS: mpMRI-guided focal boost using VMAT hypofractionated technique is associated with an excellent morphological and functional response control and a safe toxicity profile.ADVANCES IN KNOWLEDGE: In the present trial, we examined the potential role of mpMRI for radiological assessment (functional and morphological) of treatment response in high-risk prostate cancer patients treated with MRI-guided focal radiotherapy dose intensification to dominant Intraprostatic lesion.PMID:34538073 | DOI:10.1259/bjr.20210683

Source: The British Journal of Radiology - September 20, 2021 Category: Radiology Authors: Almudena Zapatero Maria Roch Pablo Castro Tejero David B üchser Carmen Martin de Vidales Saturnino Gonz ález Pablo Rodr íguez Luis Alberto San Jose Guillermo Celada Maria Teresa Murillo Source Type: research